Gerresheimer's quarterly sales recovery boosts shares

By Reuters News

- Gerresheimer GXIG.DE reported a sequential recovery in its second-quarter revenue on Wednesday, sending its shares 8% higher in early trading, as demand for its drug delivery devices boosted sales.

The German drug-packaging maker reported preliminary revenue of €578 million ($656.09 million) for the second quarter, up from €474.9 million in first quarter of the financial year.

The company's half-year earnings before interest, taxes, depreciation and amortisation fell to €168 million from €210.4 million a year ago, but it reiterated that it expected the second half of the year to be stronger, after cutting its outlook in June.

($1 = 0.8810 euros)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk